In regard to boeri et al. 'Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience'

2024-11-091365-785210.1038/s41391-022-00490-02-s2.0-85122733489http://dx.doi.org/10.1038/s41391-022-00490-0https://hdl.handle.net/20.500.14288/14845N/AOncologyUrologyNephrologyIn regard to boeri et al. 'Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience'Letter1476-5608742295700001Q11016